Thymmune

Thymmune is a biotechnology company that has developed a machine learning-enabled thymic cell engineering platform to restore normal immune function in aging and disease. The company’s cutting-edge technology in iPSC-derived thymic cell manufacturing enables the large-scale production of off-the-shelf cells. Thymmune is developing a range of therapies for treating immunodeficiency, transplant-related, and autoimmune diseases.